A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668
CompletedOBSERVATIONAL
Enrollment
64
Participants
Timeline
Start Date
January 12, 2015
Primary Completion Date
April 20, 2022
Study Completion Date
April 20, 2022
Conditions
Progressive Multiple Sclerosis
Trial Locations (1)
10117
Investigational Site Number 276001, Berlin
All Listed Sponsors
lead
Genzyme, a Sanofi Company
INDUSTRY
NCT02313285 - A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668 | Biotech Hunter | Biotech Hunter